INFORMED.
LIVE

Hikal Ltd.

BSE: HIKAL524735ISIN INE475B01022
  • Healthcare
  • Pharmaceuticals
  • BSE 1000

Share price

₹226.10+0.75 (+0.33%)
as of 18 Sep 2026
Hikal Ltd. share price, 18 Sep 2025 to 18 Sep 2026: ₹267.15 to ₹226.10 (-15.4%). Low ₹155.90, high ₹267.15. Volume shown below the price.
52W high
₹282.70
52W low
₹145.95
Off 52W high
-20.02%
1M return
+5.43%
3M return
+10.16%
6M return
+33.99%
1Y return
-15.37%
20D avg volume
1,65,251
50 DMA
₹222.18
200 DMA
₹207.35

Key ratios Consolidated

Market cap
₹2,788 Cr
Current price
₹226.10
52W high / low
₹282.70 / ₹145.95
Face value
₹2.00
P/E
-82.48
P/B
EPS (TTM)
₹-2.74
Book value / share
ROE
ROCE
-1.00%
Operating margin
Net margin
Debt / equity
0.57
Net debt
₹671.50 Cr
Interest cover
-0.26
Dividend yield
0.27%
Dividend / share (TTM)
₹0.60
Payout
Cash conversion cycle
113.6 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
402.80519.40494.30318.50380.40552.40
1.806.602.801.901.000.50
423.40470.60468.30367.40411.80484.60
194.00210.30187.60218.70182.00210.70
0.000.000.000.000.000.00
74.4067.2070.6069.6062.9063.40
14.9014.6015.5014.9017.1017.90
42.7042.0041.2041.2039.4037.70
108.80130.20109.00115.40105.60133.40
-18.8055.4028.80-47.00-30.4068.30
8.90-47.10-38.000.000.000.00
-9.908.30-9.20-47.00-30.4068.30
-2.50-6.10-3.30-12.10-8.0018.10
-7.4014.40-5.90-34.90-22.4050.20
-0.601.17-0.48-2.83-1.824.07
Key metrics
47.7064.9047.509.1026.10123.90
11.80%12.50%9.60%2.90%6.90%22.40%
-1.80%2.80%-1.20%-11.00%-5.90%9.10%
1.40%-2.00%5.00%
5.90%-6.00%
67.00%-71.30%
MetricTTMFY26FY25FY24
Income statement
1,7351,7131,860
13.1012.305.00
1,7301,7181,741
810.60798.60882.60
0.000.000.00
281.80270.30247.10
59.9062.1075.20
167.10163.80134.40
463.40460.20447.00
18.406.80123.80
-76.20-85.100.00
-57.80-78.30123.80
-24.00-29.5033.00
-33.80-48.8090.80
-2.74-3.967.36
Key metrics
169.20147.60333.40
9.75%8.60%17.90%
-1.95%-2.80%4.90%
-1.00%11.40%
-7.90%
-153.70%
153.90143.10
-6.193.09
0.570.60
671.50749.30
113.6108.4
Balance sheet
2,3652,529
884.10995.40
9.6013.00
441.60522.40
358.10334.50
38.5054.50
1,3271,357
266.50304.10
678.90789.50
681.10762.30
308.00395.10
373.10367.20
1,1991,262
Cash flow
302.00280.40
-145.30-136.50
-160.10-143.60
148.10137.30
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
402.80519.40494.30318.50380.40552.40
1.806.602.801.901.000.50
423.50470.40468.30367.20412.10484.50
194.00210.30187.60218.70182.00210.70
0.000.000.000.000.000.00
73.3066.9069.3068.1061.7061.70
14.9014.6015.5014.9017.1017.90
42.7042.0041.2041.2039.4037.70
110.00130.30110.30116.70107.10135.00
-18.9055.6028.80-46.80-30.7068.40
8.90-47.10-38.000.000.000.00
-10.008.50-9.20-46.80-30.7068.40
-2.50-6.10-3.30-12.10-8.0018.10
-7.5014.60-5.90-34.70-22.7050.30
-0.611.18-0.48-2.81-1.844.08
Key metrics
47.6065.1047.509.3025.80124.00
11.80%12.50%9.60%2.90%6.80%22.40%
-1.90%2.80%-1.20%-10.90%-6.00%9.10%
1.40%-2.00%5.00%
5.90%-6.00%
67.00%-71.00%
MetricTTMFY26FY25FY24
Income statement
1,7351,7131,860
13.1012.305.00
1,7291,7181,741
810.60798.60882.60
0.000.000.00
277.60266.00242.30
59.9062.1075.20
167.10163.80134.40
467.30464.40451.70
18.706.90123.90
-76.20-85.100.00
-57.50-78.20123.90
-24.00-29.5033.00
-33.50-48.7090.90
-2.72-3.957.37
Key metrics
169.50147.70333.50
9.77%8.60%17.90%
-1.93%-2.80%4.90%
-1.00%11.40%
-7.90%
-153.60%
154.00143.10
-6.203.08
0.570.60
671.50749.40
113.6108.4
Balance sheet
2,3652,529
884.10996.90
9.6012.90
441.60522.40
358.10334.50
38.5056.10
1,3271,357
266.30304.20
678.70789.80
681.10762.30
308.00395.10
373.10367.20
1,1991,262
Cash flow
302.10280.40
-145.30-136.50
-160.10-143.60
148.10137.30

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
68.85%
HolderTypeHoldingPreviousChange
KALYANI INVESTMENT COMPANY LIMITEDPromoter Group31.36%
CASTILIA LIFE SCIENCES LLPPromoter Group24.52%
SUGANDHA J HIREMATHPromoter7.84%
ICICI PRUDENTIAL PHARMA HEALTHCARE AND DIAGANOSTICS (P.H.D) FUNDPublic3.24%
TATA MUTUAL FUND - TATA SMALL CAP FUNDPublic2.68%
BF INVESTMENT LIMITEDPromoter Group2.65%
JAI V HIREMATHPromoter1.09%
PALLAVI ANISH SWADIPromoter0.46%
SAMEER JAI HIREMATHPromoter0.32%
SAMEER TRUSTPromoter Group0.15%
ASHOK VISHWANATH HIREMATHPromoter Group0.08%
ANIKA TRUSTPromoter Group0.06%
SUMER TRUSTPromoter Group0.06%
POOJA TRUSTPromoter Group0.06%
RHEA TRUSTPromoter Group0.06%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Final Dividend - Rs. - 0.40004 Sep 20264 Sep 2026
Interim Dividend - Rs. - 0.200017 Feb 202617 Feb 2026
Final Dividend - Rs. - 0.80002 Sep 20252 Sep 2025
Interim Dividend - Rs. - 0.60007 Feb 20258 Feb 2025
Final Dividend - Rs. - 0.60004 Sep 20244 Sep 2024

Board meetings

  • Board Meeting - Financial Results